Mye-InfoBank Publications

Lapuente-Santana, Ó, Sturm, G, Kant, J, Ausserhofer, M, Zackl, C, Zopoglou, M, McGranahan, N, Rieder, D, Trajanoski, Z, da Cunha Carvalho de Miranda, NF, Eduati, F, Finotello, F. Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion. iScience. 2024 Jul 15;27(8):110529. DOI: 10.1016/j.isci.2024.110529


Pettinella, F, Mariotti, B, Lattanzi, C, Bruderek, K, Donini, M, Costa, S, Marini, O, Iannoto, O, Gasperini, S, Caveggion, E, Castellucci, M, Calzetti, F, Bianchetto-Aguilera, F, Gardiman, E, Giani, M, Dusi, S, Cantini, M, Vassanelli, A, Pavone, D, Milella, M, Pilotto, S, Biondani, P, Höing, B, Schleupner, MC, Hussain, T, Hadaschik, B, Kaspar, C, Visco, C, Tecchio, C, Koenderman, L, Bazzoni, F, Tamassia, N, Brandau, S, Cassatella, MA, Scapini, P. Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors. Cell Reports Medicine, Volume 0, Issue 0, 101380. Jan 18, 2024; DOI: 10.1016/j.xcrm.2023.101380


Vanhaver, C, Aboubakar Nana, F, Delhez, N, Luyckx, M, Hirsch, T, Bayard, A, Houbion, C, Dauguet, N, Brochier, A, van der Bruggen, P, Bruger, AM. Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype. Life Science Alliance. Nov 2023, 7 (1) e202302332; DOI: 10.26508/lsa.202302332

Domínguez-Andrés, J, Reinecke, H, Sohrabi, Y. The immune hunger games: the effects of fasting on monocytes. Cell Mol Immunol. 2023 May 10. DOI: 10.1038/s41423-023-01033-w

Antuamwine, BB, Bosnjakovic, R, Hofmann-Vega, F, Wang, X, Theodosiou T, Iliopoulos, I, Brandau, S. N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2023 Mar;314(1):250-279. DOI: 10.1111/imr.13176

van Santvoort, M, Lapuente-Santana, Ó, Finotello, F, van der Hoorn, P, Eduati, F. Mathematically mapping the network of cells in the tumor microenvironment. bioRxiv preprint. 2023 Feb 4. DOI: 10.1101/2023.02.03.526946

 

 

Acknowlegements

COST (European Cooperation in Science and Technology)

The work from the COST Action 20117 - Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (Mye-InfoBank) is supported by COST (European Cooperation in Science and Technology).

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

www.cost.eu